H J Malling

Summary

Affiliation: Copenhagen University Hospital
Country: Denmark

Publications

  1. doi Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
    H J Malling
    Allergy Clinic, National University Hospital, Blegdamsvej 9, Copenhagen, Denmark
    Clin Exp Allergy 39:387-93. 2009
  2. ncbi [Allergology in the regional Denmark. The Danish Society for Allergology]
    Hans Jørgen Malling
    Allergiklinik, Rigshospitalet, DK 2100 København Ø
    Ugeskr Laeger 169:1094. 2007
  3. ncbi The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study
    U Bødtger
    Allergy Unit, National University Hospital, Copenhagen, Denmark
    Allergy 57:297-305. 2002
  4. ncbi Safety and tolerability of grass pollen tablets in sublingual immunotherapy--a phase-1 study
    T H Larsen
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    Allergy 61:1173-6. 2006
  5. ncbi Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study
    M S Khinchi
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    Allergy 59:45-53. 2004
  6. ncbi Time of onset of action of acrivastine in the skin of pollen-allergic subjects. A double-blind, randomized, placebo-controlled comparative study
    L J Petersen
    Department of Medicine TTA, National University Hospital, Copenhagen, Denmark
    Allergy 49:27-30. 1994
  7. ncbi Long-term repeatability of the skin prick test is high when supported by history or allergen-sensitivity tests: a prospective clinical study
    U Bodtger
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    Allergy 58:1180-6. 2003
  8. ncbi Side-effects of allergen-specific immunotherapy: a prospective multi-centre study
    L Winther
    Allergy Clinic, Copenhagen University Hospital, Rigshospitalet, Denmark
    Clin Exp Allergy 36:254-60. 2006
  9. ncbi Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets
    H J Malling
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    J Investig Allergol Clin Immunol 16:162-8. 2006
  10. ncbi Standardization of food allergen extracts for skin prick test
    K Skamstrup Hansen
    Allergy Unit, National University Hospital, Copenhagen, Denmark
    J Chromatogr B Biomed Sci Appl 756:57-69. 2001

Collaborators

Detail Information

Publications16

  1. doi Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
    H J Malling
    Allergy Clinic, National University Hospital, Blegdamsvej 9, Copenhagen, Denmark
    Clin Exp Allergy 39:387-93. 2009
    ..Patients were randomized to receive once-daily 5-grass pollen sublingual tablets of 100 IR (index of reactivity), 300 IR or 500 IR, or placebo starting 4 months before the pollen season...
  2. ncbi [Allergology in the regional Denmark. The Danish Society for Allergology]
    Hans Jørgen Malling
    Allergiklinik, Rigshospitalet, DK 2100 København Ø
    Ugeskr Laeger 169:1094. 2007
  3. ncbi The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study
    U Bødtger
    Allergy Unit, National University Hospital, Copenhagen, Denmark
    Allergy 57:297-305. 2002
    ..Birch pollen is a major cause of allergic morbidity in northern Europe and in eastern parts of North America...
  4. ncbi Safety and tolerability of grass pollen tablets in sublingual immunotherapy--a phase-1 study
    T H Larsen
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    Allergy 61:1173-6. 2006
    ..A single-centre, randomized, double-blind, placebo-controlled study. Aims: To compare the safety and tolerability of four different sublingual immunotherapy (SLIT) regimes in grass pollen allergic rhinitis...
  5. ncbi Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study
    M S Khinchi
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    Allergy 59:45-53. 2004
    ..Both sublingual allergen-specific immunotherapy (SLIT) and subcutaneous immunotherapy (SCIT) have a documented clinical efficacy, but only few comparative studies have been performed...
  6. ncbi Time of onset of action of acrivastine in the skin of pollen-allergic subjects. A double-blind, randomized, placebo-controlled comparative study
    L J Petersen
    Department of Medicine TTA, National University Hospital, Copenhagen, Denmark
    Allergy 49:27-30. 1994
    ..The results indicate that allergen SPT is a more sensitive tool for studying antihistaminergic activity than histamine SPT...
  7. ncbi Long-term repeatability of the skin prick test is high when supported by history or allergen-sensitivity tests: a prospective clinical study
    U Bodtger
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    Allergy 58:1180-6. 2003
    ..Long-term reproducibility of the skin-prick test (SPT) has been questioned. The aim of the study was to investigate the clinical relevance of SPT changes...
  8. ncbi Side-effects of allergen-specific immunotherapy: a prospective multi-centre study
    L Winther
    Allergy Clinic, Copenhagen University Hospital, Rigshospitalet, Denmark
    Clin Exp Allergy 36:254-60. 2006
    ..A clinical database was developed in order to obtain early warnings of changes in the frequency and severity of side-effects and sufficient data for the evaluation of possible risk factors...
  9. ncbi Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets
    H J Malling
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    J Investig Allergol Clin Immunol 16:162-8. 2006
    ..In conclusion, the grass allergen tablet, administered in a dose of 75000 SQ-T once daily, was well tolerated and displayed systemic immunogenicity...
  10. ncbi Standardization of food allergen extracts for skin prick test
    K Skamstrup Hansen
    Allergy Unit, National University Hospital, Copenhagen, Denmark
    J Chromatogr B Biomed Sci Appl 756:57-69. 2001
    ..30 for a commercially available hazelnut extract (Soluprick). Immunoblotting results showed a stronger IgE binding capacity and additional IgE-binding bands of the optimized hazelnut extract compared with the Soluprick extract...
  11. ncbi Sublingual immunotherapy: efficacy--methodology and outcome of clinical trials
    H J Malling
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    Allergy 61:24-8. 2006
    ..This review concludes that future SLIT studies should be planned in accordance with international recommendations in order to be conclusive...
  12. ncbi Retrospective assessment of seasonal allergic symptoms: over-rating but useful
    U Bodtger
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    Clin Exp Allergy 33:496-500. 2003
    ..Correct rating is essential when determining the efficacy of pharmaceutical treatment, indications for allergen-specific immunotherapy (SIT), or inclusion into controlled clinical studies...
  13. ncbi Grass pollen symptoms interfere with the recollection of birch pollen symptoms - a prospective study of suspected, asymptomatic skin sensitization
    K Assing
    Allergy Clinic, National University Hospital, Copenhagen, Denmark
    Allergy 62:373-7. 2007
    ..Asymptomatic skin sensitization (AS) is a risk factor for the development of allergic symptoms. A meticulous definition of this condition requires a systematic assessment of clinical symptoms before inclusion...
  14. ncbi Minimising the risks of allergen-specific injection immunotherapy
    H J Malling
    Allergy Unit, National University Hospital, Copenhagen, Denmark
    Drug Saf 23:323-32. 2000
    ..A quality assurance programme is the optimal way to minimise the risk of immunotherapy-associated systemic reactions...
  15. ncbi Objectives of training and specialty training core curriculum in allergology and clinical immunology
    H J Malling
    Section Board of Allergology and Clinical Immunology, European Union of Medical Specialists, Allergy Clinic 4222, National University Hospital, Blegdamsvej 9m DK 2100 Copenhagen, Denmark
    Allergy 59:579-88. 2004
  16. ncbi Allergen-specific immunotherapy in allergic rhinitis
    H J Malling
    Allergy Unit, National University Hospital, Copenhagen, Denmark
    Curr Opin Allergy Clin Immunol 1:43-6. 2001
    ....